Načítá se...
RAF/MEK dependence of KRAS mutant pancreatic ductal adenocarcinomas
Studies employing genetically engineered mouse models indicate that RAF activation is sufficient to induce pancreas intraepithelial neoplasms (PanINs) suggesting that MEK inhibitor-based combination approaches may have clinical utility in patients with pancreatic ductal adenocarcinomas.
Uloženo v:
| Vydáno v: | Cancer Discov |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031078/ https://ncbi.nlm.nih.gov/pubmed/22886659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-12-0308 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|